Real-time Bid/Ask 05:48:47 2024-05-29 am EDT | ||
367.51 EUR / 368.67 EUR | +0.33% |
Current month | +2.18% | ||
1 month | +2.25% |
Comparison chart between the derivative product and it's underlying value
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
Date | Price | Change |
---|---|---|
24-05-29 | 366.1 | -0.21% |
24-05-28 | 366.9 | +0.24% |
24-05-27 | 366 | -0.49% |
24-05-24 | 367.8 | +3.34% |
24-05-23 | 355.9 | -3.41% |
Delayed Quote Börse Stuttgart
Last update May 29, 2024 at 02:04 am EDT
More quotesStatic data
Product type | Certificats Discount |
---|---|
Buy / Sell | CALL |
Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
Issuer | Morgan Stanley |
WKN | ME7WV9 |
ISIN | DE000ME7WV93 |
Date issued | 2024-01-30 |
Cap | 400 $ |
Last trading day | 2024-06-21 |
Maturity | 2024-06-21 (24 Days) |
Parity | 1 : 1 |
Emission price | 356 € |
Emission volume | N/A |
Payment day | 2024-06-28 |
Bonus | - € |
Settlement | règlement en espèces |
Currency | EUR |
Technical Indicators
Discount (ask) | 10.48 % |
---|---|
Sideways yield | 0.1475 % |
Sideways yield pa | 2.341 % |
Outperformance point | 446.8 $ |
Break even | 398.59 € |
Highest since issue | 368.6 € |
Lowest since issue | 347.6 € |
Spread | 1.16 € |
Spread % | 0.31% |
Distance Cap | 46.88 $ |
Distance Cap % | +10.49% |
Max. earning | 0.543 |
Max. earning % | 0.1475 % |
Company Profile
Ratings for Vertex Pharmaceuticals Incorporated
Consensus: Vertex Pharmaceuticals Incorporated
- Stock Market
- Certificates
- Certificat